04.10.2018 • News

CRB Expands Presence in Europe

CRB Expands Presence in Europe
CRB Expands Presence in Europe

Swiss-based CRB Group, a provider of design and consulting services for the life science sector, has opened an office in Stuttgart, Germany. The office, the company’s second in Europe, supports the growing need for experts in project execution to support the pharmaceutical and biotechnology industry in the region, CRB said.

“The opening of operations for CRB in Germany strategically aligns with our clients’ growth in the region over the last decade and allows us to serve their needs locally,” said CRB president, Ryan Schroeder. “In addition, Germany’s commitment to research and manufacturing in the life science industry makes it a natural fit for the expertise of our team.”

The company has also hired Bernd Müller as the project team leader in Stuttgart. Muller previously worked at M+W group in Stuttgart, where he was the head of process department for the Bioprocess Facilities business unit. CRB said the Stuttgart office and its headquarters in Basel, Switzerland will continue to focus on life science projects in Europe. The privately held company serves markets including biotechnology, pharmaceuticals, science and technology, and food and beverage.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.